Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Data Safety Monitoring Board

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

Benzinga · Sep 1, 2022

Recap Of Friday's Biotech Catalysts - End of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

Benzinga · Jul 29, 2022

Why PolyPid Shares Are Gaining Today

The independent Data Safety Monitoring Board (DSMB) has recommended concluding enrollment in PolyPid Ltd's (NASDAQ:PYPD) SHIELD I Phase 3 study of D-PLEX100 to prevent surgical site infections (SSIs) abdominal tissue surgery. DSMB recommended stopping enrollment upon 950 patients, which is the minimum number of targeted patients in the study protocol The suggestion follows the…

Benzinga · May 23, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Safety Board Recommends BioCardia's Heart Failure Cell Therapy To Continue Unchanged

The independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for&

Benzinga · Feb 14, 2022

Coverage From

Benzinga

Organisations

European Medicines Agency

77 stories

US Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

419,697 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.